Status:
COMPLETED
Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients
Lead Sponsor:
Universita degli Studi di Genova
Collaborating Sponsors:
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Conditions:
Covid19
Hemodialysis Complication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the course of Coronavirus Disease-19 (COVID-19) uncontrolled inflammation has been related to disease severity and unfavorable outcomes. Here, the investigators study the longitudinal changes of p...
Detailed Description
For this prospective randomized study, the investigators recruit maintenance hemodialysis patients with confirmed COVID-19 infection. After diagnosis, the patients are randomized to two different dial...
Eligibility Criteria
Inclusion
- Patients undergoing maintenance hemodialysis
- Confirmed severe acute respiratory syndrome-coronavirus2 infection
Exclusion
- Acute kidney injury
Key Trial Info
Start Date :
March 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04685447
Start Date
March 16 2020
End Date
May 1 2022
Last Update
May 17 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale IRCCS San Martino
Genova, Italy
2
Policlinico IRCCS Ospedale San Matteo
Pavia, Italy